AstraZeneca PLC

52.27+0.6400+1.24%Vol 13.93M1Y Perf 3.62%
Apr 20th, 2021 16:00 DELAYED
BID52.05 ASK52.35
Open52.09 Previous Close51.63
Pre-Market- After-Market52.12
 - -  -0.15 -0.29%
Target Price
64.85 
Analyst Rating
Strong Buy 1.33
Potential %
24.07 
Finscreener Ranking
★★+     49.13
Insiders Trans % 3/6/12 mo.
-/100/100 
Value Ranking
     40.67
Insiders Value % 3/6/12 mo.
-/100/100 
Growth Ranking
★★★★     61.23
Insiders Shares Cnt. % 3/6/12 mo.
-/100/100 
Income Ranking
     33.26
Market Cap137.19B 
Earnings Rating
Buy
Price Range Ratio 52W %
31.37 
Earnings Date
30th Apr 2021

Today's Price Range

51.9552.35

52W Range

46.4864.94

5 Year PE Ratio Range

19.20126.10

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
4.88%
1 Month
6.22%
3 Months
-0.53%
6 Months
1.36%
1 Year
3.62%
3 Years
47.91%
5 Years
75.75%
10 Years
160.71%

TickerPriceChg.Chg.%
AZN52.270.64001.24
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Financial StrengthValueIndustryS&P 500US Markets
0.40
1.00
0.54
1.30
4.10
Leverage Ratio 4.60
ProfitabilityValueIndustryS&P 500US Markets
80.10
19.50
31.30
11.30
11.82
RevenueValueIndustryS&P 500US Markets
17.67B
6.73
5.92
2.07
DividendsValueIndustryS&P 500US Markets
3.60
1.86
0.00
0.00
Payout ratio147.00
Earnings HistoryEstimateReportedSurprise %
Q04 20200.530.541.89
Q03 20200.490.47-4.08
Q02 20200.440.489.09
Q01 20200.470.5312.77
Q04 20190.530.45-15.09
Q03 20190.450.5011.11
Q02 20190.300.73143.33
Q01 20190.430.454.65
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.65-74.41Negative
6/2021 QR0.57-82.62Negative
12/2021 FY2.56--
12/2022 FY3.35--
Next Report Date30th Apr 2021
Estimated EPS Next Report0.65
Estimates Count4
EPS Growth Next 5 Years %16.60
Volume Overview
Volume13.93M
Shares Outstanding2.62B
Trades Count88.41K
Dollar Volume600.14M
Avg. Volume11.15M
Avg. Weekly Volume15.30M
Avg. Monthly Volume9.70M
Avg. Quarterly Volume10.93M

AstraZeneca PLC (NYSE: AZN) stock closed at 52.27 per share at the end of the most recent trading day (a 1.24% change compared to the prior day closing price) with a volume of 13.94M shares and market capitalization of 137.19B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 76100 people. AstraZeneca PLC CEO is Pascal Soriot.

The one-year performance of AstraZeneca PLC stock is 3.62%, while year-to-date (YTD) performance is 4.56%. AZN stock has a five-year performance of 75.75%. Its 52-week range is between 46.48 and 64.94, which gives AZN stock a 52-week price range ratio of 31.37%

AstraZeneca PLC currently has a PE ratio of 41.70, a price-to-book (PB) ratio of 8.54, a price-to-sale (PS) ratio of 7.67, a price to cashflow ratio of 27.80, a PEG ratio of 2.32, a ROA of 4.79%, a ROC of 10.73% and a ROE of 21.37%. The company’s profit margin is 11.82%, its EBITDA margin is 31.30%, and its revenue ttm is $17.67 Billion , which makes it $6.73 revenue per share.

Of the last four earnings reports from AstraZeneca PLC, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.65 for the next earnings report. AstraZeneca PLC’s next earnings report date is 30th Apr 2021.

The consensus rating of Wall Street analysts for AstraZeneca PLC is Strong Buy (1.33), with a target price of $64.85, which is +24.07% compared to the current price. The earnings rating for AstraZeneca PLC stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AstraZeneca PLC has a dividend yield of 3.60% with a dividend per share of $1.86 and a payout ratio of 147.00%.

AstraZeneca PLC has a Buy technical analysis rating based on Technical Indicators (ADX : 8.59, ATR14 : 1.12, CCI20 : 192.96, Chaikin Money Flow : -0.17, MACD : 0.04, Money Flow Index : 47.04, ROC : 3.84, RSI : 59.38, STOCH (14,3) : 94.93, STOCH RSI : 1.00, UO : 54.06, Williams %R : -5.07), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AstraZeneca PLC in the last 12-months were: Nazneen Rahman (Buy at a value of $39 698), Philip A J Broadley (Buy at a value of $99 888)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
5 (83.33 %)
4 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
1 (16.67 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Moderate Buy
2.00

AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

CEO: Pascal Soriot

Telephone: +44 2037495000

Address: 1 Francis Crick Avenue, Cambridge CB2 0AA, , GB

Number of employees: 76 100

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

62%38%

Bearish Bullish

53%47%

Bearish Bullish

57%43%

News

Stocktwits